Chandan HealthcareNSE:CHANDAN +1.20%28 Dividend Yield % is 0.00% as of Jul. 06, 2026. GuruFocus rates NSE:CHANDAN with a GF Score™ of 28/100. The stock has 4 warning signs investors should review. Among 64 Medical Diagnostics & Research companies, Chandan Healthcare ranks worse than 1562498.44% on this metric.
As of today (2026-07-06), the Trailing Annual Dividend Yield of Chandan Healthcare is 0.00%.
The historical rank and industry rank for Chandan Healthcare's Dividend Yield % or its related term are showing as below:
NSE:CHANDAN's Dividend Yield % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.945 * Ranked among companies with meaningful Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Chandan Healthcare Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Chandan Healthcare's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CHANDAN vs TMO, DHR, IDXX: Dividend Yield % Comparison
For the Diagnostics & Research subindustry, Chandan Healthcare's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chandan Healthcare Dividend Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Chandan Healthcare's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Chandan Healthcare's Dividend Yield % falls into.
Chandan Healthcare (NSE:CHANDAN) has a Dividend Yield % of 0.00% as of Jul. 06, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Chandan Healthcare and its competitors. According to the industry distribution chart, Chandan Healthcare ranks #999999 out of 64 companies in the Medical Diagnostics & Research industry.
Is Chandan Healthcare's Dividend Yield % too high?
Chandan Healthcare's current Dividend Yield % is 0.00%. Based on the distribution chart, Chandan Healthcare ranks #999999 out of 64 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Chandan Healthcare has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Chandan Healthcare's Dividend Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Chandan Healthcare ranks #999999 out of 64 companies for Dividend Yield %. This places Chandan Healthcare in the lower half of its industry. The industry median Dividend Yield % is 1.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Diagnostics & Research company?
The median Dividend Yield % among Medical Diagnostics & Research companies is 1.95, based on 64 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Chandan Healthcare and its competitors. For the Medical Diagnostics & Research industry, the median Dividend Yield % is 1.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chandan Healthcare's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandan Healthcare stock overvalued right now?
Chandan Healthcare (NSE:CHANDAN) has a current Dividend Yield % of 0.00%. The current Dividend Yield % is 0.00%. Chandan Healthcare's overall GF Score™ is 28/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Chandan Healthcare (NSE:CHANDAN), the current Dividend Yield % is 0.00% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Chandan Healthcare Ltd operates laboratories that offer comprehensive pathological investigations. Its services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provide an extensive array of radiology services, including CT scans, X-rays, and MRIs. The company operates single reportable business segment that is Diagnostics Services.
28GF Score
Get the complete analysis for NSE:CHANDAN
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CHANDAN has been successfully added to your 